nodes	percent_of_prediction	percent_of_DWPC	metapath
Gonadorelin—Abortion spontaneous—Fluorouracil—urinary bladder cancer	0.0798	0.0798	CcSEcCtD
Gonadorelin—Pelvic pain—Valrubicin—urinary bladder cancer	0.0619	0.0619	CcSEcCtD
Gonadorelin—Menopause—Thiotepa—urinary bladder cancer	0.0575	0.0575	CcSEcCtD
Gonadorelin—Developmental delay—Fluorouracil—urinary bladder cancer	0.0284	0.0284	CcSEcCtD
Gonadorelin—Congenital anomaly—Fluorouracil—urinary bladder cancer	0.0284	0.0284	CcSEcCtD
Gonadorelin—Injection site reaction—Mitomycin—urinary bladder cancer	0.0258	0.0258	CcSEcCtD
Gonadorelin—Embolism—Thiotepa—urinary bladder cancer	0.0203	0.0203	CcSEcCtD
Gonadorelin—Thromboembolism—Epirubicin—urinary bladder cancer	0.0165	0.0165	CcSEcCtD
Gonadorelin—Flatulence—Valrubicin—urinary bladder cancer	0.0162	0.0162	CcSEcCtD
Gonadorelin—Thromboembolism—Doxorubicin—urinary bladder cancer	0.0153	0.0153	CcSEcCtD
Gonadorelin—Erythema—Mitomycin—urinary bladder cancer	0.0113	0.0113	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Valrubicin—urinary bladder cancer	0.011	0.011	CcSEcCtD
Gonadorelin—Injection site reaction—Gemcitabine—urinary bladder cancer	0.0109	0.0109	CcSEcCtD
Gonadorelin—Pain—Carboplatin—urinary bladder cancer	0.0106	0.0106	CcSEcCtD
Gonadorelin—Abdominal pain—Valrubicin—urinary bladder cancer	0.0106	0.0106	CcSEcCtD
Gonadorelin—Embolism venous—Epirubicin—urinary bladder cancer	0.0104	0.0104	CcSEcCtD
Gonadorelin—Asthenia—Valrubicin—urinary bladder cancer	0.00964	0.00964	CcSEcCtD
Gonadorelin—Embolism venous—Doxorubicin—urinary bladder cancer	0.00964	0.00964	CcSEcCtD
Gonadorelin—Pruritus—Valrubicin—urinary bladder cancer	0.00951	0.00951	CcSEcCtD
Gonadorelin—Diarrhoea—Valrubicin—urinary bladder cancer	0.0092	0.0092	CcSEcCtD
Gonadorelin—Shock—Mitomycin—urinary bladder cancer	0.00911	0.00911	CcSEcCtD
Gonadorelin—Swelling—Fluorouracil—urinary bladder cancer	0.00888	0.00888	CcSEcCtD
Gonadorelin—Embolism—Methotrexate—urinary bladder cancer	0.00875	0.00875	CcSEcCtD
Gonadorelin—Pelvic pain—Epirubicin—urinary bladder cancer	0.00864	0.00864	CcSEcCtD
Gonadorelin—Vomiting—Valrubicin—urinary bladder cancer	0.00855	0.00855	CcSEcCtD
Gonadorelin—Headache—Valrubicin—urinary bladder cancer	0.00842	0.00842	CcSEcCtD
Gonadorelin—Embolism—Epirubicin—urinary bladder cancer	0.00819	0.00819	CcSEcCtD
Gonadorelin—Pelvic pain—Doxorubicin—urinary bladder cancer	0.00799	0.00799	CcSEcCtD
Gonadorelin—Nausea—Valrubicin—urinary bladder cancer	0.00798	0.00798	CcSEcCtD
Gonadorelin—Fatigue—Mitomycin—urinary bladder cancer	0.00798	0.00798	CcSEcCtD
Gonadorelin—Pain—Mitomycin—urinary bladder cancer	0.00792	0.00792	CcSEcCtD
Gonadorelin—Redness—Epirubicin—urinary bladder cancer	0.00779	0.00779	CcSEcCtD
Gonadorelin—Swelling—Etoposide—urinary bladder cancer	0.00771	0.00771	CcSEcCtD
Gonadorelin—Embolism—Doxorubicin—urinary bladder cancer	0.00758	0.00758	CcSEcCtD
Gonadorelin—Redness—Doxorubicin—urinary bladder cancer	0.0072	0.0072	CcSEcCtD
Gonadorelin—Breast disorder—Cisplatin—urinary bladder cancer	0.00671	0.00671	CcSEcCtD
Gonadorelin—Asthenia—Mitomycin—urinary bladder cancer	0.00664	0.00664	CcSEcCtD
Gonadorelin—Diarrhoea—Mitomycin—urinary bladder cancer	0.00634	0.00634	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Fluorouracil—urinary bladder cancer	0.00629	0.00629	CcSEcCtD
Gonadorelin—Abdominal discomfort—Cisplatin—urinary bladder cancer	0.00616	0.00616	CcSEcCtD
Gonadorelin—Breast pain—Epirubicin—urinary bladder cancer	0.00602	0.00602	CcSEcCtD
Gonadorelin—Angiopathy—Thiotepa—urinary bladder cancer	0.00595	0.00595	CcSEcCtD
Gonadorelin—Immune system disorder—Thiotepa—urinary bladder cancer	0.00592	0.00592	CcSEcCtD
Gonadorelin—Vomiting—Mitomycin—urinary bladder cancer	0.00589	0.00589	CcSEcCtD
Gonadorelin—Headache—Mitomycin—urinary bladder cancer	0.0058	0.0058	CcSEcCtD
Gonadorelin—Erythema—Thiotepa—urinary bladder cancer	0.00571	0.00571	CcSEcCtD
Gonadorelin—Breast pain—Doxorubicin—urinary bladder cancer	0.00557	0.00557	CcSEcCtD
Gonadorelin—Nausea—Mitomycin—urinary bladder cancer	0.0055	0.0055	CcSEcCtD
Gonadorelin—Injection site reaction—Epirubicin—urinary bladder cancer	0.00522	0.00522	CcSEcCtD
Gonadorelin—Angiopathy—Gemcitabine—urinary bladder cancer	0.005	0.005	CcSEcCtD
Gonadorelin—Immune system disorder—Gemcitabine—urinary bladder cancer	0.00498	0.00498	CcSEcCtD
Gonadorelin—Injection site reaction—Doxorubicin—urinary bladder cancer	0.00483	0.00483	CcSEcCtD
Gonadorelin—Erythema—Gemcitabine—urinary bladder cancer	0.0048	0.0048	CcSEcCtD
Gonadorelin—Erythema—Fluorouracil—urinary bladder cancer	0.00472	0.00472	CcSEcCtD
Gonadorelin—Immune system disorder—Cisplatin—urinary bladder cancer	0.00464	0.00464	CcSEcCtD
Gonadorelin—Nervous system disorder—Thiotepa—urinary bladder cancer	0.00457	0.00457	CcSEcCtD
Gonadorelin—Erythema—Cisplatin—urinary bladder cancer	0.00447	0.00447	CcSEcCtD
Gonadorelin—Flatulence—Cisplatin—urinary bladder cancer	0.00441	0.00441	CcSEcCtD
Gonadorelin—Angiopathy—Etoposide—urinary bladder cancer	0.00427	0.00427	CcSEcCtD
Gonadorelin—Immune system disorder—Etoposide—urinary bladder cancer	0.00425	0.00425	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00402	0.00402	CcSEcCtD
Gonadorelin—Fatigue—Thiotepa—urinary bladder cancer	0.00401	0.00401	CcSEcCtD
Gonadorelin—Pain—Thiotepa—urinary bladder cancer	0.00398	0.00398	CcSEcCtD
Gonadorelin—Constipation—Thiotepa—urinary bladder cancer	0.00398	0.00398	CcSEcCtD
Gonadorelin—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.00392	0.00392	CcSEcCtD
Gonadorelin—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00385	0.00385	CcSEcCtD
Gonadorelin—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.00384	0.00384	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00381	0.00381	CcSEcCtD
Gonadorelin—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.00378	0.00378	CcSEcCtD
Gonadorelin—Breast disorder—Methotrexate—urinary bladder cancer	0.00368	0.00368	CcSEcCtD
Gonadorelin—Abdominal pain—Thiotepa—urinary bladder cancer	0.00368	0.00368	CcSEcCtD
Gonadorelin—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.00365	0.00365	CcSEcCtD
Gonadorelin—Nervous system disorder—Cisplatin—urinary bladder cancer	0.00358	0.00358	CcSEcCtD
Gonadorelin—Breast disorder—Epirubicin—urinary bladder cancer	0.00345	0.00345	CcSEcCtD
Gonadorelin—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00343	0.00343	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00338	0.00338	CcSEcCtD
Gonadorelin—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.00338	0.00338	CcSEcCtD
Gonadorelin—Fatigue—Gemcitabine—urinary bladder cancer	0.00338	0.00338	CcSEcCtD
Gonadorelin—Pain—Gemcitabine—urinary bladder cancer	0.00335	0.00335	CcSEcCtD
Gonadorelin—Constipation—Gemcitabine—urinary bladder cancer	0.00335	0.00335	CcSEcCtD
Gonadorelin—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00335	0.00335	CcSEcCtD
Gonadorelin—Asthenia—Thiotepa—urinary bladder cancer	0.00334	0.00334	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00333	0.00333	CcSEcCtD
Gonadorelin—Pruritus—Thiotepa—urinary bladder cancer	0.00329	0.00329	CcSEcCtD
Gonadorelin—Pain—Fluorouracil—urinary bladder cancer	0.00329	0.00329	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Methotrexate—urinary bladder cancer	0.00327	0.00327	CcSEcCtD
Gonadorelin—Breast disorder—Doxorubicin—urinary bladder cancer	0.00319	0.00319	CcSEcCtD
Gonadorelin—Diarrhoea—Thiotepa—urinary bladder cancer	0.00319	0.00319	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00315	0.00315	CcSEcCtD
Gonadorelin—Pain—Cisplatin—urinary bladder cancer	0.00312	0.00312	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.00306	0.00306	CcSEcCtD
Gonadorelin—Vomiting—Thiotepa—urinary bladder cancer	0.00296	0.00296	CcSEcCtD
Gonadorelin—Headache—Thiotepa—urinary bladder cancer	0.00292	0.00292	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00289	0.00289	CcSEcCtD
Gonadorelin—Fatigue—Etoposide—urinary bladder cancer	0.00288	0.00288	CcSEcCtD
Gonadorelin—Pain—Etoposide—urinary bladder cancer	0.00286	0.00286	CcSEcCtD
Gonadorelin—Constipation—Etoposide—urinary bladder cancer	0.00286	0.00286	CcSEcCtD
Gonadorelin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00284	0.00284	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.00284	0.00284	CcSEcCtD
Gonadorelin—Asthenia—Gemcitabine—urinary bladder cancer	0.00281	0.00281	CcSEcCtD
Gonadorelin—Pruritus—Gemcitabine—urinary bladder cancer	0.00277	0.00277	CcSEcCtD
Gonadorelin—Nausea—Thiotepa—urinary bladder cancer	0.00277	0.00277	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00274	0.00274	CcSEcCtD
Gonadorelin—Pruritus—Fluorouracil—urinary bladder cancer	0.00273	0.00273	CcSEcCtD
Gonadorelin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00269	0.00269	CcSEcCtD
Gonadorelin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00268	0.00268	CcSEcCtD
Gonadorelin—Abdominal pain—Etoposide—urinary bladder cancer	0.00264	0.00264	CcSEcCtD
Gonadorelin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00264	0.00264	CcSEcCtD
Gonadorelin—Asthenia—Cisplatin—urinary bladder cancer	0.00262	0.00262	CcSEcCtD
Gonadorelin—Angiopathy—Methotrexate—urinary bladder cancer	0.00256	0.00256	CcSEcCtD
Gonadorelin—Immune system disorder—Methotrexate—urinary bladder cancer	0.00255	0.00255	CcSEcCtD
Gonadorelin—Diarrhoea—Cisplatin—urinary bladder cancer	0.0025	0.0025	CcSEcCtD
Gonadorelin—Vomiting—Gemcitabine—urinary bladder cancer	0.00249	0.00249	CcSEcCtD
Gonadorelin—Hypersensitivity—Etoposide—urinary bladder cancer	0.00246	0.00246	CcSEcCtD
Gonadorelin—Erythema—Methotrexate—urinary bladder cancer	0.00246	0.00246	CcSEcCtD
Gonadorelin—Headache—Gemcitabine—urinary bladder cancer	0.00245	0.00245	CcSEcCtD
Gonadorelin—Vomiting—Fluorouracil—urinary bladder cancer	0.00245	0.00245	CcSEcCtD
Gonadorelin—Headache—Fluorouracil—urinary bladder cancer	0.00241	0.00241	CcSEcCtD
Gonadorelin—Asthenia—Etoposide—urinary bladder cancer	0.0024	0.0024	CcSEcCtD
Gonadorelin—Angiopathy—Epirubicin—urinary bladder cancer	0.00239	0.00239	CcSEcCtD
Gonadorelin—Immune system disorder—Epirubicin—urinary bladder cancer	0.00238	0.00238	CcSEcCtD
Gonadorelin—Pruritus—Etoposide—urinary bladder cancer	0.00237	0.00237	CcSEcCtD
Gonadorelin—Nausea—Gemcitabine—urinary bladder cancer	0.00233	0.00233	CcSEcCtD
Gonadorelin—Vomiting—Cisplatin—urinary bladder cancer	0.00232	0.00232	CcSEcCtD
Gonadorelin—Erythema—Epirubicin—urinary bladder cancer	0.0023	0.0023	CcSEcCtD
Gonadorelin—Diarrhoea—Etoposide—urinary bladder cancer	0.00229	0.00229	CcSEcCtD
Gonadorelin—Nausea—Fluorouracil—urinary bladder cancer	0.00229	0.00229	CcSEcCtD
Gonadorelin—Flatulence—Epirubicin—urinary bladder cancer	0.00226	0.00226	CcSEcCtD
Gonadorelin—Angiopathy—Doxorubicin—urinary bladder cancer	0.00222	0.00222	CcSEcCtD
Gonadorelin—Immune system disorder—Doxorubicin—urinary bladder cancer	0.00221	0.00221	CcSEcCtD
Gonadorelin—Nausea—Cisplatin—urinary bladder cancer	0.00217	0.00217	CcSEcCtD
Gonadorelin—Vomiting—Etoposide—urinary bladder cancer	0.00213	0.00213	CcSEcCtD
Gonadorelin—Erythema—Doxorubicin—urinary bladder cancer	0.00213	0.00213	CcSEcCtD
Gonadorelin—Headache—Etoposide—urinary bladder cancer	0.0021	0.0021	CcSEcCtD
Gonadorelin—Flatulence—Doxorubicin—urinary bladder cancer	0.00209	0.00209	CcSEcCtD
Gonadorelin—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.002	0.002	CcSEcCtD
Gonadorelin—Nausea—Etoposide—urinary bladder cancer	0.00199	0.00199	CcSEcCtD
Gonadorelin—Nervous system disorder—Methotrexate—urinary bladder cancer	0.00196	0.00196	CcSEcCtD
Gonadorelin—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.00188	0.00188	CcSEcCtD
Gonadorelin—Shock—Epirubicin—urinary bladder cancer	0.00184	0.00184	CcSEcCtD
Gonadorelin—Nervous system disorder—Epirubicin—urinary bladder cancer	0.00184	0.00184	CcSEcCtD
Gonadorelin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.00173	0.00173	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00173	0.00173	CcSEcCtD
Gonadorelin—Fatigue—Methotrexate—urinary bladder cancer	0.00173	0.00173	CcSEcCtD
Gonadorelin—Pain—Methotrexate—urinary bladder cancer	0.00171	0.00171	CcSEcCtD
Gonadorelin—Shock—Doxorubicin—urinary bladder cancer	0.00171	0.00171	CcSEcCtD
Gonadorelin—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.0017	0.0017	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.00162	0.00162	CcSEcCtD
Gonadorelin—Fatigue—Epirubicin—urinary bladder cancer	0.00162	0.00162	CcSEcCtD
Gonadorelin—Pain—Epirubicin—urinary bladder cancer	0.0016	0.0016	CcSEcCtD
Gonadorelin—Constipation—Epirubicin—urinary bladder cancer	0.0016	0.0016	CcSEcCtD
Gonadorelin—Abdominal pain—Methotrexate—urinary bladder cancer	0.00158	0.00158	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.00153	0.00153	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.0015	0.0015	CcSEcCtD
Gonadorelin—Fatigue—Doxorubicin—urinary bladder cancer	0.0015	0.0015	CcSEcCtD
Gonadorelin—Pain—Doxorubicin—urinary bladder cancer	0.00148	0.00148	CcSEcCtD
Gonadorelin—Constipation—Doxorubicin—urinary bladder cancer	0.00148	0.00148	CcSEcCtD
Gonadorelin—Abdominal pain—Epirubicin—urinary bladder cancer	0.00148	0.00148	CcSEcCtD
Gonadorelin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.00148	0.00148	CcSEcCtD
Gonadorelin—Asthenia—Methotrexate—urinary bladder cancer	0.00144	0.00144	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.00142	0.00142	CcSEcCtD
Gonadorelin—Pruritus—Methotrexate—urinary bladder cancer	0.00142	0.00142	CcSEcCtD
Gonadorelin—Hypersensitivity—Epirubicin—urinary bladder cancer	0.00138	0.00138	CcSEcCtD
Gonadorelin—Abdominal pain—Doxorubicin—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Gonadorelin—Diarrhoea—Methotrexate—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Gonadorelin—Asthenia—Epirubicin—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Gonadorelin—Pruritus—Epirubicin—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Gonadorelin—Diarrhoea—Epirubicin—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Gonadorelin—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Gonadorelin—Vomiting—Methotrexate—urinary bladder cancer	0.00127	0.00127	CcSEcCtD
Gonadorelin—Headache—Methotrexate—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Gonadorelin—Asthenia—Doxorubicin—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Gonadorelin—Pruritus—Doxorubicin—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Gonadorelin—Vomiting—Epirubicin—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Gonadorelin—Nausea—Methotrexate—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Gonadorelin—Diarrhoea—Doxorubicin—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Gonadorelin—Headache—Epirubicin—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Gonadorelin—Nausea—Epirubicin—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Gonadorelin—Vomiting—Doxorubicin—urinary bladder cancer	0.0011	0.0011	CcSEcCtD
Gonadorelin—Headache—Doxorubicin—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Gonadorelin—Nausea—Doxorubicin—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
